Clinical Trial Update: Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-PD-1 therapy in combination with thermal ablation for advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED